SCWorx (WORX) Research & Development (2019)

SCWorx's (WORX) quarterly Research & Development came in at $198450.0 in Q3 2019, down 58.48% quarter-over-quarter from $477950.0 in Q2 2019.

Analysis

SCWorx (WORX) Research & Development (2019) Analysis & Trends

SCWorx has disclosed Research & Development across 1 years of filings, most recently posting $198450.0 for Q3 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Veeva Systems	42.69 Bn	35.44 Bn	695.95 Mn	222.92 Mn
2	Waystar Holding	4.56 Bn	4.37 Bn	221.99 Mn	50.38 Mn
3	Doximity	4.44 Bn	3.75 Bn	132.93 Mn	45.05 Mn
4	CCC Intelligent Solutions Holdings	3.91 Bn	3.79 Bn	210.64 Mn	52.99 Mn
5	Schrodinger	1.45 Bn	1.03 Bn	32.43 Mn	41.00 Mn
6	EverCommerce	1.22 Bn	1.09 Bn	119.50 Mn	33.72 Mn
7	Certara	1.18 Bn	992.06 Mn	58.15 Mn	14.98 Mn
8	GoodRx Holdings	1.16 Bn	862.52 Mn	179.41 Mn	81.99 Mn
9	Healthstream	832.62 Mn	765.89 Mn	54.72 Mn	13.58 Mn
10	SCWorx	406,173.97	-857,304.03	330,423.00	-

Historic Data

Download Data